eMultipleSclerosis

eMultipleSclerosis Review is a component of the popular eLiterature Review series by Johns Hopkins School of Medicine providing #CME on #MultipleSclerosis.

[Multiple Sclerosis News Today @MSNewsToday]

High-dose vitamin D as an add-on treatment for MS provides modest but significant benefits to patients, a meta-analysis showed. https://t.co/QgJVCtraaE #MultipleSclerosis #MSTreatment #MSResearch #MSNews

[Immunic Therapeutics @ImmunicInc]

📖 How early does #MultipleSclerosis (#MS) really begin?

A new third-party study published in @JAMANetworkOpen showed that increased health care use including mental health visits can be seen more than a decade before diagnosis.

At #Immunic, our mission is to advance new therapies that could make a real difference for people living with MS. Insights into the prodromal phase of the disease are crucial, as they may one day pave the way towards earlier detection and, ultimately, earlier and more effective treatment options.

Read the full study here: 🔗 https://t.co/qOdh2CD4D9

#MSResearch #neurology #vidofludimus #IMU838 #IMUX

[MSJ @MSJ_Research]

4w hypnosis (HYP) and mindfulness (MM) audio recordings improved fatigue impact, sleep disturbance and depressive symptoms in people with #MultipleSclerosis, compared with treatment as usual (TAU).

A randomized controlled study from @KevinAlschuler @UW ▶️ https://t.co/RoXOoa6TZH

[MSJ @MSJ_Research]

40% of people with #MultipleSclerosis reported misdiagnosis of their symptoms, which was in turn associated with longer diagnostic time, suggesting we need to trace the diagnostic journey to understand/prevent delays.

Registry study from @UVMLarnerMed
▶️ https://t.co/vq8qHGnJWn

[Pavan Bhargava @PavanBhargavaMD]

We demonstrate that the alterations in the MS circulating metabolome can have important functional consequences. We identify a potential mechanism to correct this imbalance to promote repair while also suppressing inflamamtion.
https://t.co/QRxQ53esRE

[eMultipleSclerosis @DKB_MS]

New CME/CE video podcast! Dr. Haiwen Chen and Dr. Karla Gray-Roncal — two MS specialists from the Johns Hopkins University School of Medicine — discuss Pediatric Onset Multiple Sclerosis. @hopkinsneurons

Watch here: https://t.co/mQG9Cw8GQa

[eMultipleSclerosis @DKB_MS]

New Volume of eMultipleSclerosis Review is launching this Sunday! 👀

It'll feature guest authors from @HopkinsMedicine @StonyBrookMed @ClevelandClinic @OSUWexMed and more.

Stay tuned for more info!

[Earl K. Sneed @EarlKSneed]

It’s been an honor to join the 2024 #BlackMSExperience Summit, and to learn from several experts and health professionals in the Multiple Sclerosis community. Thank you to the @mssociety for bringing everyone together and highlighting African-Americans in the MS community.

[Multiple Sclerosis News Today @MSNewsToday]

Explore why scientists say resistance training may be especially beneficial for middle-aged and older MS patients: https://t.co/NC9zykAKIg

#MS #MultipleSclerosis #MSResearch #MSNews #MSAndExercise

[NeurologyLive® @neurology_live]

@DanOntaneda, of @ClevelandClinic, discussed several notable presentations and topics from the 2024 #ACTRIMSForum, highlighting advances in #MS care. #ACTRIMS @ACTRIMS

🎥 https://t.co/NyOI0PuNZf

[MS Canada @MSCanOfficial]

🌙💤 Happy #WorldSleepDay! Today, we're reflecting on how sleep can affect life with MS. Just ask Jean-Sébastien – a restful night can make all the difference! How do you prioritize sleep in your routine? Share your tips! #MultipleSclerosis #MS

[eMultipleSclerosis @DKB_MS]

We have a great variety of podcasts available for you, check them out on your favorite podcast app or by going to https://t.co/CYoYsZa2un

#Podcast #PodcastForClinicians #PodcastAboutMedicine #MedicinePodcasts #MultipleSclerosis #Neurologist

[Dr. Brandon Beaber @Brandon_Beaber]

The potential role of EBV and multiple sclerosis and how b-cell depleters (ocrevus, kesimpta, briumvi, rituximab) may work by killing autoreactive EBV-infected b-lymphocytes. https://t.co/zHl40NS7MU

[Gabrielle Macaron @GMacaronMD]

We finally present the results of or multinational (7 centers) study on adult-onset leukodystrophies misdiagnosed or occurring with #MultipleSclerosis at @ECTRIMS #MSMilan2023 - paper coming up soon @ClevelandClinic @HopPitieSalpe @ChumNeuro @TheNeuro_MNI

[ECTRIMS @ECTRIMS]

#MSMilan2023 | Welcome to the first day of the joint ECTRIMS / @ACTRIMS meeting! Thank you for joining the #MS research community to make every person and every pathway count.

📽️ Watch MS expert @HannekeHulst from @UniLeidenNews present today’s Daily Highlights. 👇 👇 👇

[eMultipleSclerosis @DKB_MS]

Earn CME/CE credit by reading the newsletter!

https://t.co/yIWtgxdasq

[eMultipleSclerosis @DKB_MS]

How burdensome is spasticity for patients with MS? What’s the approach to treatment, and how effective is it? What do patients and clinicians need to know about cannabis-based therapies? @mdkornberg discusses these questions with #MS spasticity experts.

https://t.co/lwno9w6XiI

[WVU Rockefeller Neuroscience Institute @WVURNI]

Learn about MS with WVU Neurology's Dr. Melanie Ward. #MSAwarenessMonth

[Multiple Sclerosis News Today @MSNewsToday]

We sat down with @NerdyNeuroMD to discuss health inequities among Black people with MS and the documentary "MS in Blacks and Africans Americans" that premiered at #actrims2023. Check out what she had to say, and stay tuned for the full story! https://t.co/xCbku9RSPP #actrims #MS

[Barry Singer MD 🧠 @drbarrysinger]

Chertcoff: #Psychiatric disorders common prior to first #MS relapse. Risk was 55-78% higher than controls without MS in the 5 years prior to diagnosis. Also, more psychiatric hospitalizations and use of psychotropic meds. #Depression & #anxiety common. #ACTRIMS2023 #ACTRIMSForum